A rare case of Miller Fisher variant of Guillain-Barré Syndrome (GBS) induced by a checkpoint inhibitor

With the recent development of novel, more potent cancer treatment, in particular, immune ‘checkpoint inhibitors’, cases of neurological immune-related adverse events are on the rise. Although rare, this includes Guillain-Barré Syndrome (GBS). We present the case of a 68-year-old male who was admitt...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:BMJ Case Rep
المؤلفون الرئيسيون: McNeill, Caitlin Jane, Fehmi, Janev, Gladwin, James, Price, Christopher
التنسيق: Artigo
اللغة:Inglês
منشور في: BMJ Publishing Group 2019
الموضوعات:
Unexpected Outcome (Positive or Negative) Including Adverse Drug Reactions
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC6700679/
https://ncbi.nlm.nih.gov/pubmed/31413049
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2019-229443
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة